UPLOAD Filing
Anixa Biosciences Inc
Date: Sept. 16, 2025 · CIK: 0000715446 · Accession: 0000000000-25-010013
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-290178
Letter
Re: Anixa Biosciences Inc Registration Statement on Form S-3 Filed September 10, 2025 File No. 333-290178 Dear Amit Kumar Ph.D.:
September 16, 2025
Amit Kumar, Ph.D. Chairman and Chief Executive Officer Anixa Biosciences Inc 3150 Almaden Expressway, Suite 250 San Jose, CA 95118
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Chris Edwards at 202-551-6761 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Matthew Bernstein, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> September 16, 2025 Amit Kumar, Ph.D. Chairman and Chief Executive Officer Anixa Biosciences Inc 3150 Almaden Expressway, Suite 250 San Jose, CA 95118 Re: Anixa Biosciences Inc Registration Statement on Form S-3 Filed September 10, 2025 File No. 333-290178 Dear Amit Kumar Ph.D.: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Chris Edwards at 202-551-6761 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Matthew Bernstein, Esq. </TEXT> </DOCUMENT>